Tiger Global led a $133m Series E funding round in Virta Health.

Tiger Global led a $133m Series E funding round in Virta Health, a company developing type 2 diabetes reversal. “The norm in diabetes care has been more medications, more weight gain, and more suffering. Diabetes reversal changes this. We have shown a path for people to live medication and diabetes-free, and this investment is about reaching even more people and taking diabetes reversal mainstream,” Sami Inkinen, Virta Health Co-Founder and CEO.